Biogen Inc.
BIIBNASDAQHealthcare● Active
$192.62
$-2.72(-1.39%)
Market Cap$28.4B
P/E Ratio—
52W High$205.97
52W Low$121.05
Biogen Inc.（BIIB）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BIIB · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $1.29B | $1.63B | $1.16B | $2.96B | $1.73B |
| Depreciation & Amort. | $0.78B | $0.67B | $0.49B | $0.52B | $0.49B |
| Stock-Based Comp. | $0.29B | $0.29B | $0.26B | $0.25B | $0.24B |
| Change in Working Capital | ($1.06B) | ($0.16B) | ($0.65B) | ($0.89B) | ($0.15B) |
| Net Cash from Operations | $2.20B | $2.88B | $1.55B | $1.38B | $3.64B |
| Investing Activities | |||||
| Capital Expenditure | ($0.15B) | ($0.36B) | ($0.31B) | ($0.24B) | ($0.26B) |
| Purchases of Investments | ($1.26B) | $0.00B | ($5.14B) | ($3.45B) | ($3.81B) |
| Sales of Investments | $0.08B | $0.55B | $8.29B | $4.66B | $3.50B |
| Net Cash from Investing | ($1.37B) | ($0.80B) | ($4.09B) | $1.59B | ($0.56B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | ($0.75B) | ($1.80B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.02B) | ($0.65B) | $0.19B | ($1.00B) | ($0.17B) |
| Net Cash from Financing | ($0.30B) | ($0.68B) | $0.14B | ($1.76B) | ($2.09B) |
| Free Cash Flow | |||||
| Free Cash Flow | $2.05B | $2.52B | $1.24B | $1.14B | $3.38B |
| FCF Margin %(computed) | 20.90% | 26.00% | 12.56% | 11.25% | 30.79% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Biogen Inc.
关于Biogen Inc.（BIIB）现金流量表
Biogen Inc. 2025财年经营活动现金流$2.20B，自由现金流$2.05B（FCF利润率20.90%），资本支出($0.15B)。
常见问题
BIIB · 4 问Biogen Inc. 2025财年自由现金流$2.05B，同比down18.5%。
BIIB free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10